期刊文献+

干扰素类药物在病毒性肝炎中的现代应用与评价 被引量:4

原文传递
导出
摘要 对目前投入临床运用的α、β、γ干扰素,复合干扰素及长效干扰素在治疗乙、丙型肝炎方面的国外最新研究与应用现状和不良反应进行了总结.
出处 《国际病毒学杂志》 2008年第3期-,共7页 International Journal of Virology
  • 相关文献

参考文献26

  • 1Lavanchy D. Hepatitis B virus epidemiology,disease burden,treat-ment,and current and emerging prevention and control measures[J].Journal of Viral Hepatitis,2004,(02):97-107.doi:10.1046/j.1365-2893.2003.00487.x.
  • 2Ganem D,Prince AM. Hepatitis B virus infection--natural history and clinical consequanees[J].New England Journal of Medicine,2004,(11):1118-1129.doi:10.1056/NEJMra031087.
  • 3Mallat DB,El-Serag FIB. Interferon for postresection recurrence of hepatoeellular carcinoma[J].American Journal of Gastroenterology,2002,(12):3200-3202.
  • 4Camma C,Di Bona D,Sehepis F. Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C:a meta-analysis of indi-vidual patient data[J].Hepatology,2004,(02):333-342.doi:10.1002/hep.20073.
  • 5Andreone P,Gramensi A,Cursaro C. Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C:results of a randomized controlled pilot trial[J].Journal of Viral Hepatitis,2004,(01):69-73.doi:10.1046/j.1365-2893.2003.00470.x.
  • 6Flamm SL. Chronic hepatitis C virus infection[J].Journal of the American Medical Association,2003,(18):2413-2417.
  • 7Sehulte-Frohlinde E,Seidler B,Burkard I. Different activities of type Ⅰ interferons on hepatitis B virus core promoter regulated transcription[J].Cytokine,2002,(04):214-220.doi:10.1006/cyto.2001.1000.
  • 8Moskovitz DN,Manoharan P,Heathcote EJ. High dose consensus interferon in nonresponders to interferon alpha-2b and ribavirin with chronic hepatitis C[J].Canadian Journal of Gastroenterology=journal Canadien De Gastroenterologie,2003,(08):479-482.
  • 9Kaito M,Yasui-Kawamura N,lwasa M. Twice-a-day versus once-a-day interfaron-beta therapy in chronic hepatitis C[J].Hepato-Gastroenterology,2003,(03):755-778.
  • 10Sato Y,lchida T,Ito S. Preoperative administration of 5-FUand interferon beta may prevent recurrence Of hepatitis B and C virus[J].American Journal of Gastroenterology,2002,(01):215-216.

同被引文献43

  • 1程书权,段刚.药源性流感样综合征[J].国外医学(呼吸系统分册),2004,24(3):168-170. 被引量:6
  • 2丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 3张久聪,董茜,邵彬.胸腺肽α1的作用机制和临床应用[J].细胞与分子免疫学杂志,2006,22(4):547-549. 被引量:55
  • 4张经良,李涛.干扰素α-2b联合胸腺肽α1治疗慢性乙型肝炎临床疗效分析[J].临床肝胆病杂志,2007,23(1):43-44. 被引量:9
  • 5Asian Pacific Association for the Study of the Liver (APASL) Hepatitis C Working Party.McCaughan GW, Omata M, Amarapurkar D ,et al.Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis,management and treatment of hepatitis C virus infection [J].J Gastroenterol Hepatol, 2007,22 (5) : 615-633.
  • 6Tran HA.The swinging thyroid in hepatitis C infection and interferon th erapy[J].QJM ,2010,103(3) : 187-191.
  • 7Jiskra J,Antosov M ,Lmanov Z,et al.The relationship between thyroid function,serum monokine induced by interferon gamma and soluble inerleukin-2 receptor in thyroid autoimmune diseases[J].Clin Exp Immunol,2009,156(2):211-216.
  • 8Kong YV, Wei WZ, Tomer Y. Opportunistic autoimmune disorders:from immunotherapy to Immune dysregulation[J].Ann N Y Acad Sci, 2010, 1183 : 222-236.
  • 9Jamil KM, Leedman PJ, Kontorinis N, et al.Interferon-induced thyroiddysfunction in chronic hepatitis C[J].J Gastroenterol Hep- atol,2009,24(6) : 1017-1023.
  • 10Di Bisceglie AM,Ghalib RH,Hamzeh FM,et al.Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C[J].Viral Hepat,2011,14(6) :721-729.

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部